What is Aytu BioScience Inc (AYTU) stock price today?

Aytu BioScience Inc (AYTU) currently trades at $2.58 per share. The stock has a market capitalization of $27.05M and a P/E ratio of —x.

Is AYTU stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Aytu BioScience Inc has a Smart Value Score of 31/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Aytu BioScience Inc's revenue and earnings?

Aytu BioScience Inc has trailing twelve-month (TTM) revenue of $62.64M with profit margins of -39.00%. Earnings per share (EPS) is $-3.44.

AYTU

Aytu BioScience Inc

NASDAQ: AYTU · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC

$2.58

+2.38% today

Updated 2026-04-30

Market cap

$27.05M

P/E ratio

—

P/S ratio

0.43x

EPS (TTM)

$-3.44

Dividend yield

—

52W range

$1 – $3

Volume

0.0M

Market cap

$27.05M

P/E ratio

—

P/S ratio

0.43x

EPS (TTM)

$-3.44

Dividend yield

—

52W range

$1 – $3

Volume

0.0M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

2.7

Growth

5.0

Quality

C+

2.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target

$9.33

+261.63%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Free cash flow $3.66M — positive

Risks

- Thin margins at -39.00%

- Revenue declining -6.50% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$96.67M	$107.40M	$65.18M	$66.38M	$62.64M
Net income	$-108.78M	$-17.05M	$-15.84M	$-13.56M	$-10.58M
EPS	—	—	—	—	$-3.44
Free cash flow	$-31.16M	$-5.13M	$-1.72M	$-5.17M	$3.66M
Profit margin	-112.53%	-15.88%	-24.31%	-20.43%	-39.00%

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
AYTU	$27.05M	31	2.7	2.0	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Aytu BioScience Inc trades at $2.58. Our Smart Value Score of 31/100 indicates the stock is weak. TTM revenue stands at $62.64M. with profit margins at -39.00%.

Frequently asked questions

What is Aytu BioScience Inc's stock price?

Aytu BioScience Inc (AYTU) trades at $2.58.

Is Aytu BioScience Inc overvalued?

Smart Value Score 31/100 (Grade F, Strong Sell).

What is the price target of Aytu BioScience Inc (AYTU)?

The analyst target price is $9.33, representing +261.6% upside from the current price of $2.58.

What is Aytu BioScience Inc's revenue?

TTM revenue is $62.64M.

Company info

SectorHEALTHCARE

IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio0.43x

ROE-109.20%

Beta0.28

50D MA$2.54

200D MA$2.39

Shares out0.01B

Float0.01B

Short ratio—

Avg volume0.0M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

AYTU vs LLY →AYTU vs JNJ →AYTU vs ABBV →Stock screener →